Published in Neuropsychopharmacology on October 01, 2004
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther (2010) 1.39
Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci (2012) 1.17
Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett (2007) 1.04
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci (2009) 0.95
Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci (2012) 0.93
Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci (2013) 0.90
Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res (2007) 0.89
Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord (2008) 0.89
Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res (2013) 0.84
Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. J Psychiatr Res (2014) 0.80
Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression. J Child Adolesc Psychopharmacol (2012) 0.79
Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand (2013) 0.78
N-acetylaspartate normalization in bipolar depression after lamotrigine treatment. Bipolar Disord (2014) 0.76
Prospective neurochemical characterization of child offspring of parents with bipolar disorder. Psychiatry Res (2013) 0.76
Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study. J Affect Disord (2016) 0.75
Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res (2008) 5.99
Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res (2009) 3.68
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry (2005) 3.23
Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry (2002) 2.74
Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res (2010) 2.47
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res (2005) 2.16
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biol Psychiatry (2012) 1.85
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry (2013) 1.85
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse. Bipolar Disord (2009) 1.82
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry (2010) 1.80
Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord (2007) 1.78
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.76
Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull (2003) 1.74
An MRI study of increased cortical thickness in autism. Am J Psychiatry (2006) 1.72
Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res (2008) 1.71
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv (2009) 1.62
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
Increased frontal cortical folding in autism: a preliminary MRI study. Psychiatry Res (2004) 1.58
The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry (2007) 1.57
Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull (2008) 1.56
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54
A voxel-based morphometry study of frontal gray matter correlates of impulsivity. Hum Brain Mapp (2009) 1.48
Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry (2006) 1.43
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord (2006) 1.41
Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett (2002) 1.39
The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am J Psychiatry (2008) 1.39
Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry (2004) 1.38
Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull (2009) 1.36
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull (2003) 1.34
Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry (2002) 1.34
Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry (2006) 1.33
Disruption of white matter integrity in bipolar depression as a possible structural marker of illness. Biol Psychiatry (2011) 1.33
A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry (2009) 1.33
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res (2004) 1.30
Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev (2003) 1.28
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology (2007) 1.27
Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry (2004) 1.26
Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res (2004) 1.26
Anatomical MRI study of borderline personality disorder patients. Psychiatry Res (2004) 1.23
Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry (2005) 1.23
Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry (2008) 1.21
An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res (2008) 1.20
Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20
Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull (2004) 1.19
Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. J Child Neurol (2003) 1.19
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
Insight and frontal cortical function in schizophrenia: a review. Schizophr Res (2006) 1.18
"Just the facts": meandering in schizophrenia's many forests. Schizophr Res (2011) 1.18
Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull (2012) 1.17
Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage (2003) 1.17
Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res (2006) 1.16
A review of feature reduction techniques in neuroimaging. Neuroinformatics (2014) 1.16
Corpus callosum volume in children with autism. Psychiatry Res (2009) 1.16
Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry (2004) 1.16
A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. J Child Adolesc Psychopharmacol (2008) 1.15
Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry (2002) 1.14
Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med (2006) 1.13
Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.12
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12